Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors

Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors

Background: The timing of imaging for 68gallium (68Ga)-PSMA and 68Ga-DOTATOC are stated to be around 60 min post-injection (p.i.). In some lesions, late imaging (3–4 h p.i.) showed advantages. The aim of our evaluation was to demonstrate the relevance of an “early” late acquisition. Methods: We retr...

Full description

Saved in:
Bibliographic Details
Main Authors: Librizzi, Damiano, Eilsberger, Friederike, Ottenthaler, Stefan, Ebrahimifard, Ali, Luster, Markus, Yousefi, Behrooz H.
Format: Article
Language:English
Published: Philipps-Universität Marburg 2023
Subjects:
Medizin
neuroendocrine tumor
DOTATOC
PSMA
dual-time
prostate cancer
PET/CT
68gallium
Medical sciences Medicine
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

PDF Full Text

Holdings details from
Call Number: urn:nbn:de:hebis:04-es2024-02863
Publication Date: 2024-01-15
Source: Erstveröffentlichung: Librizzi, D.; Eilsberger, F.; Ottenthaler, S.; Ebrahimifard, A.; Luster, M.; Yousefi, B.H. Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors. Biomedicines 2023, 11, 1052. https://doi.org/10.3390/biomedicines11041052
Downloads: 47 (2024)
License: https://creativecommons.org/licenses/by/4.0
Access URL: https://archiv.ub.uni-marburg.de/es/2024/0286
https://doi.org/10.3390/biomedicines11041052

Similar Items